Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent

Nanchen, 2017, Is atherosclerosis imaging the most sensitive way to assess patients’ risk and the best way to conduct future drug trials? A pros-and-cons debate, Atherosclerosis, 266, 229, 10.1016/j.atherosclerosis.2017.08.024 Wisniewska, 2017, Anti-atherosclerotic action of agmatine in ApoE-Knockout mice, Int. J. Mol. Sci., 18, 10.3390/ijms18081706 Choi, 2009, Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake, Circ. Res., 104, 1355, 10.1161/CIRCRESAHA.108.192880 Wu, 2017, New insights into the role of inflammation in the pathogenesis of atherosclerosis, Int. J. Mol. Sci., 18, 10.3390/ijms18102034 Barbieri, 2004, Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms, Free Radic. Biol. Med., 37, 156, 10.1016/j.freeradbiomed.2004.04.020 Park, 2012, Oxidized LDL/CD36 interaction induces loss of cell polarity and inhibits macrophage locomotion, Mol. Biol. Cell, 23, 3057, 10.1091/mbc.e11-12-1051 Rizzacasa, 2017, LOX-1 and its splice variants: a new challenge for atherosclerosis and cancer-targeted therapies, Int. J. Mol. Sci., 18, 10.3390/ijms18020290 Moore, 2013, Macrophages in atherosclerosis: a dynamic balance, Nat. Rev. Immunol., 13, 709, 10.1038/nri3520 Ference, 2018, Impact of lipids on cardiovascular health: JACC health promotion series, J. Am. Coll. Cardiol., 72, 1141, 10.1016/j.jacc.2018.06.046 Grevengoed, 2014, Acyl-CoA metabolism and partitioning, Annu. Rev. Nutr., 34, 1, 10.1146/annurev-nutr-071813-105541 Li, 2005, Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis, J. Biol. Chem., 280, 21763, 10.1074/jbc.M501759200 Lim, 2008, Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo, Circulation, 117, 940, 10.1161/CIRCULATIONAHA.107.711275 Tall, 2015, Cholesterol, inflammation and innate immunity, Nat. Rev. Immunol., 15, 104, 10.1038/nri3793 Duewell, 2010, NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals, Nature, 464, 1357, 10.1038/nature08938 Hansson, 2006, Soderberg-naucler, C. inflammation and atherosclerosis, Annu. Rev. Pathol., 1, 297, 10.1146/annurev.pathol.1.110304.100100 Taleb, 2016, Inflammation in atherosclerosis, Arch. Cardiovasc. Dis., 109, 708, 10.1016/j.acvd.2016.04.002 Viola, 2015, Atherosclerosis – A matter of unresolved inflammation, Semin. Immunol., 27, 184, 10.1016/j.smim.2015.03.013 Yvan-Charvet, 2010, ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation, Science, 328, 1689, 10.1126/science.1189731 Mao, 2016, Traditional Chinese medicine, Danlou tablet alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study, BMC Complement. Altern. Med., 16, 447, 10.1186/s12906-016-1406-4 Qi, 2018, Protective effects of Danlou Tablet against murine myocardial ischemia and reperfusion injury in vivo, Chin. J. Integr. Med., 24, 613, 10.1007/s11655-016-2448-7 Gao, 2015, The anti-inflammatory activities of ethanol extract from Dan-Lou prescription in vivo and in vitro, BMC Complement. Altern. Med., 15, 317, 10.1186/s12906-015-0848-4 Wang, 2016, Efficacy of Danlou Tablet in patients with Non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results from a multicentre, placebo-controlled, randomized trial, Evid. Complement. Alternat. Med., 10.1155/2016/7960503 Dong, 2013, Qualitative and quantitative analysis of the major constituents in Chinese medicinal preparation Dan-Lou Tablet by ultra high performance liquid chromatography/diode-array detector/quadrupole time-of-flight tandem mass spectrometry, J. Pharm. Biomed. Anal., 80, 10.1016/j.jpba.2013.02.011 Ruytinx, 2018, Chemokine-induced macrophage polarization in inflammatory conditions, Front. Immunol., 9, 1930, 10.3389/fimmu.2018.01930 Moore, 2011, Macrophages in the pathogenesis of atherosclerosis, Cell, 145, 341, 10.1016/j.cell.2011.04.005 Stewart, 2010, CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer, Nat. Immunol., 11, 155, 10.1038/ni.1836 Mercurio, 1999, Multiple signals converging on NF-kappaB, Curr. Opin. Cell Biol., 11, 226, 10.1016/S0955-0674(99)80030-1 Roy, 2016, Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways, Int. Immunopharmacol., 40, 79, 10.1016/j.intimp.2016.08.026 Feng, 2014, TLR4/NF-kappaB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells, Genet. Mol. Res., 13, 680, 10.4238/2014.January.28.13 Lusis, 2000, Nature, 407, 233, 10.1038/35025203 Li, 2002, The macrophage foam cell as a target for therapeutic intervention, Nat. Med., 8, 1235, 10.1038/nm1102-1235 Yvan-Charvet, 2008, Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions, Circulation, 118, 1837, 10.1161/CIRCULATIONAHA.108.793869 Zhu, 2010, Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol, J. Lipid Res., 51, 3196, 10.1194/jlr.M006486 Rajamaki, 2010, Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation, PLoS One, 5, 10.1371/journal.pone.0011765